Showing results (661-670 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|June 21, 2014
Is there a higher risk of CNS adverse events for PI monotherapy versus triple therapy? A review of results from randomized clinical trialsWilliam Powderly, Andrew Hill, Christiane Moecklinghoff
HIV Clinical Trials|June 21, 2014
The problem of renal function monitoring in patients treated with the novel antiretroviral drugsPaolo Maggi, Vincenzo Montinaro, Stefano Rusconi, et al.
HIV Clinical Trials|June 21, 2014
Rate, predictors, and consequences of late antenatal booking in a national cohort study of pregnant women with HIV in ItalyM Floridia, C Pinnetti, M Ravizza, et al.
HIV Clinical Trials|April 16, 2015
Differential skeletal impact of tenofovir disoproxil fumarate in young versus old HIV-infected adultsPhilip M Grant, Douglas Kitch, Grace A McComsey, et al.
HIV Clinical Trials|November 9, 2012
ARIES 144 week results: durable virologic suppression in HIV-infected patients simplified to unboosted atazanavir/abacavir/lamivudineKathleen E Squires, Benjamin Young, Edwin DeJesus, et al.
HIV Clinical Trials|November 9, 2012
Increase in standard cholesterol and large HDL particle subclasses in antiretroviral-naïve patients prescribed efavirenz compared to atazanavir/ritonavirDaria Gotti, Bruno Mario Cesana, Laura Albini, et al.
HIV Clinical Trials|November 9, 2012
Feasibility and reliability of interactive voice response assessment of HIV medication adherence: research and clinical implicationsJennifer E Hettema, Sharzad Hosseinbor, Karen S Ingersoll
HIV Clinical Trials|November 9, 2012
Switch from etravirine twice daily to once daily in non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-infected patients with suppressed viremia: the Monetra studyL Schneider, N Ktorza, S Fourati, et al.
HIV Clinical Trials|November 9, 2012
Missing scheduled visits in the outpatient clinic as a marker of short-term admissions and deathMaría Martínez Colubi, María Jesús Pérez-Elías, Laura Elías, et al.
HIV Clinical Trials|April 17, 2007
Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naïve HIV-infected individuals from 40 United States citiesLisa Ross, Michael L Lim, Qiming Liao, et al.
Pageof 68